Dose optimization of sotorasib: Has the burden of proof for the labeled dose been met?

Eur J Cancer. 2024 Nov:212:115044. doi: 10.1016/j.ejca.2024.115044. Epub 2024 Sep 27.

Authors

Sanjay Popat¹, Mark J Ratain²

Affiliations

¹ Lung Unit, Royal Marsden Hospital, London, UK; Division of Clinical Studies, Institute of Cancer Research, London, UK.
² The University of Chicago, Chicago, IL, USA. Electronic address: [email protected].

PMID: 39357278
DOI: 10.1016/j.ejca.2024.115044

No abstract available

Publication types

Editorial